Moisand Fitzgerald Tamayo’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-2
Closed 914
2022
Q2
$0 Sell
2
-2
-50% ﹤0.01% 702
2022
Q1
$0 Buy
+4
New ﹤0.01% 686